Results 71 to 80 of about 20,217 (209)

Sex hormones, obesity and type 2 diabetes: is there a link?

open access: yesEndocrine Connections, 2019
An imbalance in sex hormones has an important impact on type 2 diabetes (T2DM) mainly through the involvement of visceral adipose tissue. Androgens have an interesting sex-dimorphic association with T2DM, since hyperandrogenism in females and ...
Alessandra Gambineri, Carla Pelusi
doaj   +1 more source

Vaporised etomidate (“space oil”) misuse: A narrative review

open access: yesHong Kong Journal of Emergency Medicine, Volume 33, Issue 5, October 2026.
Abstract Background Etomidate, a well‐established intravenous induction agent valued for haemodynamic stability, has emerged as a recreational drug via e‐cigarette vaping (“space oil”), particularly in Asia, including Hong Kong, prompting regulatory controls amid rising emergency presentations.
Sui Wa Au, Yu‐Yeung Yip
wiley   +1 more source

A cross-sectional comparison of clinical and endocrine parameters among phenotypes of polycystic ovarian syndrome in iranian population

open access: yesMiddle East Fertility Society Journal, 2018
Background and objective: Polycystic ovary syndrome (PCOS), as a major hormonal issue among reproductive age women, is categorized into four phenotypes regarding hyperandrogenism, oligo-anovulation and polycystic ovary morphology.
Payam Amini   +4 more
doaj   +1 more source

Subclinical cardiac alterations and cardiometabolic profile in adolescents with newly diagnosed polycystic ovary syndrome: A cross‐sectional comparative echocardiographic study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 310-321, October 2026.
Abstract Objective While cardiometabolic comorbidities have been well established in adults with polycystic ovary syndrome (PCOS), it remains unclear whether the early signs of cardiovascular morbidity emerge during adolescence. This study aimed to investigate whether metabolic and cardiovascular alterations begin in adolescents with PCOS.
Demet Aygün Ari   +8 more
wiley   +1 more source

Efficacy and related factors of levonorgestrel‐releasing intrauterine system combined with metformin in fertility‐preserving treatment for atypical endometrial hyperplasia and early endometrial cancer: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 396-407, October 2026.
Abstract Objective To compare the efficacy of the levonorgestrel‐releasing intrauterine system combined with metformin versus oral progestin combined with metformin in fertility‐preserving treatment for patients with atypical endometrial hyperplasia and early endometrial cancer, and to analyze related factors affecting efficacy.
Pengpeng Gu   +5 more
wiley   +1 more source

Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome): An extreme subphenotype of polycystic ovary syndrome

open access: yes, 2020
HAIR-AN-a syndrome of hyperandrogenism (HA), insulin resistance (IR) and acanthosis nigricans (AN)-is a specific subphenotype of polycystic ovary syndrome (PCOS), and it is seen in almost 5% of all women with hyperandrogenism.
Dahiya, Rachana   +2 more
core   +1 more source

Gonadotropin Releasing Hormone (GnRH) Agonist Improves Hyperandrogenism in an Adolescent Female with a Novel Insulin Receptor Gene Mutation

open access: yes, 2019
We describe a case of an adolescent female with Type A insulin resistance whose severe hirsutism and hyperandrogenism were improved with leuprolide, despite extreme hyperinsulinemia.
Lujan, Maria E.   +4 more
core   +1 more source

Polycystic ovary syndrome and menopausal transition: Hormonal dynamics, phenotypic evolution, and ethnic considerations

open access: yes
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 11, Page 2371-2372, November 2026.
Danxi Lv
wiley   +1 more source

Very low dose of flutamide in the treatment of hyperandrogenism

open access: yes, 2017
Hyperandrogenism is a condition affecting 5–10% of adolescents. The aim of this study was to evaluate the efficacy of very low dose of flutamide in the treatment of hyperandrogenism in adolescence.
MELIS, FEDERICA   +9 more
core   +1 more source

The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome

open access: yesGynecological Endocrinology
Objective This study aimed to investigate the impact of serum androgen levels on metabolic profiles in patients with polycystic ovary syndrome (PCOS).Methods We included 216 patients with PCOS and 216 healthy individuals selected as the control group ...
Zhao Ting   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy